Insider Transactions in Q3 2023 at Oncternal Therapeutics, Inc. (ONCT)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 03
2023
|
James B Breitmeyer Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Indirect |
4,007
-16.75%
|
$0
$0.36 P/Share
|
|
Jul 03
2023
|
James B Breitmeyer Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
47,992
-8.85%
|
$0
$0.36 P/Share
|
|
Jul 03
2023
|
Rajesh Krishnan CTO/CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,897
-16.32%
|
$0
$0.36 P/Share
|
|
Jul 03
2023
|
Salim Yazji Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,299
-9.9%
|
$0
$0.36 P/Share
|
|
Jul 03
2023
|
Richard G Vincent Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,069
-4.51%
|
$0
$0.36 P/Share
|
|
Jul 03
2023
|
Chase C. Leavitt General Counsel/Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
10,305
-9.64%
|
$0
$0.36 P/Share
|